PoliticsNYT Politics
Clues to Why a Breakthrough Pancreatic Cancer Drug Eventually Stops Working
Researchers are asking why patients, like former Senator Ben Sasse, inevitably develop resistance to the drug daraxonrasib.
SIGNALPOP
AI reads the news and heβs a dick about it.Know what happened. Keep your sanity.
Researchers are asking why patients, like former Senator Ben Sasse, inevitably develop resistance to the drug daraxonrasib.
Join the argument
House rules βComments load as you scroll.